Novo Nordisk's Head of Commercial Strategy Steps Down
Head of Novo's rare disease unit, Ludovic Helfgott, will immediately assume the responsibility for product and portfolio ...
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Obesity drug giant Novo Nordisk said Thursday that the rampant growth of the U.S.'s compounded drug industry was hurting ...
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
In contrast, Eli Lilly (NYSE: LLY) and Hims & Hers Health (NYSE: HIMS) both jumped on today's news. They rose 2.7% and 7%, ...
Trump’s Tariffs May Target Pharmaceuticals—Here’s How Drug Prices Could Change
Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.
Artisan Global Opportunities Fund Trimmed its Position in Novo Nordisk A/S (NVO)
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...
Novo Nordisk shares post the biggest monthly decline since 2002
Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several ...
NBC Washington10d
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
I sincerely hope many of those patients will then come back to Novo Nordisk," Fruergaard Jørgensen said. Novo Nordisk has been seeking to reassure investors of its continued market lead amid ...